Clinical Trial: Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Nonsmall Cell Lung Cancer Stage III
Study Type: INTERVENTIONAL
Official Title: Phase II Pilot Study of Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Brief Summary:
This research study aims to determine what effects (good and bad) Durvalumab has on participants and their cancer with a "quick start" of Durvalumab within 14 days of finishing chemotherapy and radiation.The study will also determine the logistic barriers to the quick start of Durvalumab.
Read more